Details of the Drug | DrugMAP

General Information of Drug (ID: DMF7V9W)

Drug Name

MPC-2130

Synonyms

MPC-176716; MPI-176716

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Structure

3D Structure is Not Available

3D MOL

2D MOL

Cross-matching ID

TTD ID: D04YAK

References

1	ClinicalTrials.gov (NCT00387153) Phase 1 Clinical Trial MPC-2130 Treatment of Blood Cancers / Refractory Cancer. U.S. National Institutes of Health.